Sana Intidhar Labidi‐Galy

2026

Profiling tumor immune microenvironment of epithelial ovarian carcinoma.

Oncoimmunology ·doi:10.1080/2162402x.2026.2722470

BackgroundEpithelial ovarian carcinoma (EOC) comprises five main histological subtypes: high-grade serous (HGSOC), low-grade serous (LGSOC), clear cell (CCOC), mucinous (MOC), and endometrioid (ENOC). Each histotype harbors specific genomic…

2024

Window of opportunity with PD1 blockade before chemoradiotherapy for an advanced stage clear cell carcinoma of the cervix.

Gynecologic oncology reports ·doi:10.1016/j.gore.2024.101394

Clear cell carcinoma is a rare and very aggressive subset of cervical cancer, with poor outcome if diagnosed at advanced stage. There are few data available on the optimal management of this histotype, and treatment recommendations that inc…

review 2020

Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets—a narrative review

Annals of translational medicine ·doi:10.21037/atm-20-3022a

Abstract: Endometriosis is a benign gynecologic condition affecting up to one woman out of ten of reproductive age. It is defined by the presence of endometrial-like tissue in localizations outside of the uterine cavity. It often causes sym…

2014

Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.

Gynecologic Oncology ·doi:10.1016/j.ygyno.2014.01.026

ObjectiveTo investigate the neutrophil-to-lymphocyte ratio (NLR) from peripheral blood, a general measure of inflammation, in ovarian cancer.MethodsWhite cell counts and CA125 levels before treatment, tumor features, and questionnaire data …